Our sister site, Drug Delivery Business News, reports today that the company won FDA clearance for the 15-day version of its latest-generation G7 CGM. Clearance makes the 15-day G7 the longest-lasting wearable CGM, according to the company.

The company says its 15-day G7 also meets integrated CGM (iCGM) standards from the FDA, meaning it would work with compatible insulin delivery systems.

According to Dexcom, the latest offering brings several features of the existing G7 platform. That includes a waterproof sensor, connectivity to the Apple Watch, plus automated activity, simplified meal and new medication logging. Its 12-hour grace period allows a seamless transition when replacing sensors as well.